Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS??? EQUITY

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Consultants and Independent Financial Advisors	Employees	Preferred Stock	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Consultants and Independent Financial Advisors	Additional Paid-In Capital Employees	Accumulated Deficit	Noncontrolling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	$ 395,176			$ 2	$ 20	$ 520,135			$ (125,004)	$ 23
Beginning Balance (in shares) at Dec. 31, 2017				17,012,075	198,583,941
Beginning Balance at Dec. 31, 2017	370,391			$ 2	$ 20	520,135			(149,778)	12
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock purchase plan (in shares)					122,192
Issuance of common stock under employee stock purchase plan	365					365
Exercise of stock options, net of shares tendered in payment of exercise price (in shares)					2,285,314
Exercise of stock options, net of shares tendered in payment of exercise price	3,636					3,636
Stock-based compensation		$ 34	$ 4,408				$ 34	$ 4,408
Issuance of restricted stock (in shares)					2,115,000
Issuance of restricted stock	0
Unvested restricted stock forfeitures (in shares)					(106,250)
Repurchase and retirement of common stock (in shares)					(2,748,401)
Repurchase and retirement of common stock	(8,746)					(8,746)
Preferred stock issued, net of underwriting discount and expense	(180)					(180)
Preferred stock dividends declared and paid	(25,523)					(25,523)
Common stock dividends declared and paid	(6,377)					(6,377)
Net income	24,224								24,202	22
Ending Balance (in shares) at Sep. 30, 2018				17,012,075.000	200,251,796.000
Ending Balance at Sep. 30, 2018	387,017			$ 2	$ 20	487,752			(100,802)	45
Beginning Balance (in shares) at Jun. 30, 2018				17,012,075	201,271,034
Beginning Balance at Jun. 30, 2018	391,163			$ 2	$ 20	501,348			(110,239)	32
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock purchase plan (in shares)					32,891
Issuance of common stock under employee stock purchase plan	84					84
Exercise of stock options, net of shares tendered in payment of exercise price (in shares)					778,234
Exercise of stock options, net of shares tendered in payment of exercise price	1,304					1,304
Stock-based compensation		7	1,373				7	1,373
Unvested restricted stock forfeitures (in shares)					(106,250)
Repurchase and retirement of common stock (in shares)					(1,724,113)
Repurchase and retirement of common stock	(5,318)					(5,318)
Preferred stock issued, net of underwriting discount and expense	(91)					(91)
Preferred stock dividends declared and paid	(8,507)					(8,507)
Common stock dividends declared and paid	(2,448)					(2,448)
Net income	9,450								9,437	13
Ending Balance (in shares) at Sep. 30, 2018				17,012,075.000	200,251,796.000
Ending Balance at Sep. 30, 2018	387,017			$ 2	$ 20	487,752			(100,802)	45
Beginning Balance (in shares) at Dec. 31, 2018				17,012,075	146,535,796
Beginning Balance at Dec. 31, 2018	253,177			$ 2	$ 14	344,356			(91,246)	51
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock purchase plan (in shares)					127,507
Issuance of common stock under employee stock purchase plan	342					342
Exercise of stock options, net of shares tendered in payment of exercise price (in shares)					2,529,429
Exercise of stock options, net of shares tendered in payment of exercise price	1,372					1,372
Stock-based compensation		15	4,459				$ 15	4,459
Issuance of restricted stock (in shares)					2,785,000
Issuance of restricted stock	$ 1				$ 1
Unvested restricted stock forfeitures (in shares)	(82,500)				(82,500)
Repurchase and retirement of common stock (in shares)					(3,184,451)
Repurchase and retirement of common stock	$ (10,873)					(10,873)
Preferred stock issued, net of underwriting discount and expense (in shares)				389,207
Preferred stock issued, net of underwriting discount and expense	9,431					9,431
Preferred stock dividends declared and paid	(25,987)					(25,987)
Common stock dividends declared and paid	(5,380)					(5,380)
Net income	22,217								22,275	(58)
Ending Balance (in shares) at Sep. 30, 2019				17,401,282.000	148,710,781.000
Ending Balance at Sep. 30, 2019	248,774			$ 2	$ 15	317,735			(68,971)	(7)
Beginning Balance (in shares) at Jun. 30, 2019				17,401,282	148,501,131
Beginning Balance at Jun. 30, 2019	246,690			$ 2	$ 15	326,928			(80,327)	72
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock purchase plan (in shares)					40,869
Issuance of common stock under employee stock purchase plan	92					92
Exercise of stock options, net of shares tendered in payment of exercise price (in shares)					324,352
Exercise of stock options, net of shares tendered in payment of exercise price	$ 218					218
Stock-based compensation		$ 0	$ 1,536					$ 1,536
Unvested restricted stock forfeitures (in shares)	0
Repurchase and retirement of common stock (in shares)					(155,571)
Repurchase and retirement of common stock	$ (526)					(526)
Preferred stock issued, net of underwriting discount and expense	(18)					(18)
Preferred stock dividends declared and paid	(8,702)					(8,702)
Common stock dividends declared and paid	(1,793)					(1,793)
Net income	11,277								11,356	(79)
Ending Balance (in shares) at Sep. 30, 2019				17,401,282.000	148,710,781.000
Ending Balance at Sep. 30, 2019	$ 248,774			$ 2	$ 15	$ 317,735			$ (68,971)	$ (7)